-
Interim Prediction of Two-year All-cause Mortality in Patients with de novo Multivessel Coronary Artery Disease Undergoing Intended Multivessel PCI
M Renkens
- In 563 patients, the median predicted 2-year all-cause mortality was 1.9%
- Older age, impaired LVEF, and an increased anatomical SYNTAX-I score were the main contributors to high mortality
- Accurate prediction helps in
- Mortality risk prediction
- 3VD patients to make informed choices
- Utilize intravascular imaging techniques for the disease
-
Percutaneous Coronary Intervention and Medical Therapy versus Medical Therapy Alone in Chronic Coronary Syndrome: A Hierarchical Win-ratio Analysis from SCAAR
S Von Koc
- Revascularization with PCI did not result in better outcomes when compared to medical therapy alone
- For patients with CCS, medical therapy may be just as effective as PCI in improving outcomes
-
Predicting the Death Caused by Cardiovascular and/or Cerebrovascular Disease within 7 Years Follow-up Using Machine Learning Models
K Tsarapatsani
- LightGBM was the most accurate model, achieving 87.56 %
- Machine learning models achieved accurate prediction of cardiovascular and cerebrovascular death for 7 years of follow-up utilizing basic medical data
-
Updating Cardiovascular Disease Risk Prediction Equations to Account for Lipid-lowering Treatment Drop-in During Follow-up: A National Data-linkage Cohort
J Liang
- Incorporating a time-dependent lipid-lowering medication effect is an effective approach for addressing treatment drop-in in CVD risk prediction equations
- Traditional methods to evaluate model performance are unable to identify the impact of treatment drop-in
- Digital health in hypertension management: utile or futile
Using Apps in Hypertension: A Way to Improve Blood Pressure
A Mihailidou
- Apps incorporating more comprehensive functionalities will be more effective
- The goal is Engagement
- Partnership between patient, caregiver, and physicians to empower adherence to self-management
- Assess health literacy and cultural sensitivities
- Verify that it has been tested for equivalent efficacy for low and high socioeconomic status people
- Guideline-directed medical therapy in heart failure: novel implementation strategies
Novel Strategies in Heart Failure Management
A Rakisheva
- Rapid up-titration of HF therapies is safe and reduces HF readmissions or all-cause deaths
- HFpEF patients have heterogeneous clinical profiles
- Haemodynamic monitoring
- Improved quality of life
- Reduced heart failure hospitalisations
-
Hot Papers in Risk Factors and Comorbidities in Hypertension
M Camafort
- Discussed 4 papers
- Sacubitril/Valsartan may have advantages over valsartan in reversing ventricular remodeling
- Ticagrelor Aspirin showed a greater effect in patients without hypertension than those with stroke
- RIGHT: Prolongation of anticoagulant after primary PCI
Post-procedural Anticoagulation After PCI for ST-segment Elevation Myocardial Infarction (STEMI): A Multicentre, Randomised, Double-blind Trial
P Vranckx
- Anticoagulation after PCI does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI)
- Routine Prolonged post-procedural anticoagulation (PPA) after PCI is safe but does not improve ischaemic outcomes at 30 days
- 3 anticoagulants could not prevent 30-day ischaemic events
